Side effects of multiple sclerosis drugs can be reduced
New investigation from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have discovered how a drug for multiple sclerosis interacts with its targets. this may be a landmark way for better treatments. Multiple sclerosis prevalence has increased worldwide, also the failure of drugs and its outcomes in treating has caused severe drawbacks in field of medicine.
The study published in Nature Communications found the detailed precise molecular structure of the multiple sclerosis drug siponimod that interacts with its target, and off-target receptors using a cutting-edge electron microscopy technique.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd